Published Studies Related to Lithium Carbonate
Well-designed clinical trials related to Lithium Carbonate
Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb
randomised sequential trial. [2012]
Efficacy and safety of lithium carbonate treatment of chronic spinal cord injuries: a double-blind, randomized, placebo-controlled clinical trial. [2011.11.22]
Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. [2011.06]
Lithium carbonate pre-treatment in 131-I therapy of hyperthyroidism. [2011]
Treatment of suicide attempters with bipolar disorder: a randomized clinical
trial comparing lithium and valproate in the prevention of suicidal behavior. [2011]
Differential pattern of response in mood symptoms and suicide risk measures in
severely ill depressed patients assigned to citalopram with placebo or citalopram
combined with lithium: role of lithium levels. [2011]
Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study. [2010.11]
Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine. [2010.09]
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. [2010.08.17]
Olanzapine vs. lithium in management of acute mania. [2010.05]
Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. [2010.03]
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. [2010.01.30]
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. [2010.01.30]
Olanzapine vs. lithium in management of acute mania. [2010]
A double-blind, placebo-controlled study with quetiapine as adjunct therapy with
lithium or divalproex in bipolar I patients with coexisting alcohol dependence. [2010]
Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. [2010]
Safety and efficacy of lithium in combination with riluzole for treatment of
amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled
trial. [2010]
Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar
II disorder: a randomized, double-blind, placebo-substitution study. [2010]
Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients
Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized,
Double-blind, Placebo-Controlled Trial. [2010]
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. [2009.06]
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). [2009.04]
Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. [2009.02]
Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. [2009.02]
A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. [2009.01]
[Open randomized comparative twelve-week study of lithium and valproate in manic episode] [2009]
Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms. [2008.12]
Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. [2008.12]
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. [2008.09]
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. [2008.08]
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). [2008.08]
Serotonin transporter gene and response to lithium augmentation in depression. [2008.04]
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. [2008.04]
What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review? [2008.03]
Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2008.01]
Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium. [2007.10]
Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2007.05.23]
Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study. [2007.05]
Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial. [2007.05]
Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse. [2007.04]
Lithium and triiodothyronine augmentation of antidepressants. [2006.10]
Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. [2006.04]
Inositol augmentation of lithium or valproate for bipolar depression. [2006.04]
Bioequivalence of two lithium formulations in healthy volunteers. [2006]
Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect. [2005.08]
Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. [2005.05]
Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? [2005.01]
Suicide prevention by lithium SUPLI--challenges of a multi-center prospective study. [2005]
Well-designed clinical trials possibly related to Lithium Carbonate
Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients
with bipolar disorder: a randomized double blind placebo controlled clinical
trial. [2014]
Comparative efficacy and acceptability of drug treatments for bipolar depression:
a multiple-treatments meta-analysis. [2014]
Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on
treatment to mood stabilizers and/or antipsychotic agents in manic patients with
bipolar disorder. [2014]
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar
disorder. [2013]
Characterizing relapse prevention in bipolar disorder with adjunctive
ziprasidone: clinical and methodological implications. [2013]
The paroxetine 352 bipolar trial: A study in medical ghostwriting. [2012]
Asenapine as adjunctive treatment for acute mania associated with bipolar
disorder: results of a 12-week core study and 40-week extension. [2012]
Quetiapine: a pharmacoeconomic review of its use in bipolar disorder. [2012]
Treatment of mixed bipolar states. [2012]
Polarity index of pharmacological agents used for maintenance treatment of
bipolar disorder. [2012]
Modeling drop-outs in amyotrophic lateral sclerosis. [2012]
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of
bipolar I disorder: long-term changes in weight and metabolic profiles. [2012]
Comparative efficacy and acceptability of mood stabilizer and second generation
antipsychotic monotherapy for acute mania--a systematic review and meta-analysis. [2011]
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of
depression in patients with bipolar I disorder: a randomized, double-blind,
placebo-controlled trial. [2011]
Aripiprazole in the maintenance treatment of bipolar disorder: a critical review
of the evidence and its dissemination into the scientific literature. [2011]
Ziprasidone for maintenance treatment of bipolar I disorder in adults. [2011]
LICAVAL: combination therapy in acute and maintenance treatment of bipolar disorder. [2010.06.23]
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. [2010.04]
Acute and preventive pharmacologic treatment of cluster headache. [2010]
Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar
disorder in adults. [2010]
A single-blind, comparative study of zotepine versus haloperidol in combination
with a mood stabilizer for patients with moderate-to-severe mania. [2010]
Aripiprazole for the maintenance treatment of bipolar I disorder: A review. [2010]
An algorithm for the pharmacological treatment of depression. [2010]
Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression. [2009.08]
Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? [2009.05]
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). [2009.02]
[Relapse rate within 6 months after successful ECT: a naturalistic prospective peer- and self-assessment analysis] [2009]
Impact of remitted substance use disorders on the future course of bipolar I disorder: Findings from a clinical trial. [2008.07.15]
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. [2008.03]
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. [2007.12]
Facial emotion processing in acutely ill and euthymic patients with pediatric bipolar disorder. [2007.08]
Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. [2007.01]
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). [2006.12]
Maintenance treatment outcomes in older patients with bipolar I disorder. [2005.04]
Cognitive therapy vs medications in the treatment of moderate to severe depression. [2005.04]
Obesity among outpatients with major depressive disorder. [2005.03]
Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. [2005.01]
Other research related to Lithium Carbonate
Standard and trace-dose lithium: a systematic review of dementia prevention and
other behavioral benefits. [2014]
Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or
quetiapine-treated outpatients with bipolar I or II disorder: results from the
Bipolar CHOICE trial. [2014]
Gene-expression differences in peripheral blood between lithium responders and
non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). [2014]
Prescribing patterns of lithium or lithium+valproate in manic or mixed episodes:
a naturalistic study. [2013]
Lithium in the prevention of suicide in mood disorders: updated systematic review
and meta-analysis. [2013]
Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in
relapse prevention of manic or mixed episodes in bipolar I patients stratified by
index manic or mixed episode. [2013]
Investigation into the long-term metabolic effects of aripiprazole adjunctive to
lithium, valproate, or lamotrigine. [2013]
Efficacy and mood conversion rate during long-term fluoxetine v. lithium
monotherapy in rapid- and non-rapid-cycling bipolar II disorder. [2013]
Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]. [2011.09.21]
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. [2011.09.06]
Comparison of intermittent haemodialysis, prolonged intermittent renal replacement therapy and continuous renal replacement haemofiltration for lithium toxicity: a case report. [2011.06]
Changes in the pharmacokinetics of digoxin in polyuria in streptozotocin-induced diabetic mice and lithium carbonate-treated mice. [2011.06]
Lithium-induced sinus node dysfunction at therapeutic serum levels. [2011.05]
Fatal lithium toxicity with therapeutic levels--a case report. [2011.05]
Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations. [2011.04.01]
[Difficulty in determining when to end continuous hemodialysis for lithium intoxication: case report]. [2011.03]
Lithium use and primary hyperparathyroidism. [2011.03]
|
